David Sabatini, MD, PhD
David M. Sabatini is a biochemist and cell biologist with a long-standing interest in the regulation of growth. He is most recognized for his work on the signaling pathway anchored by the mTOR kinase, which Sabatini discovered when he was a student and has continued to study since then.
Sabatini was born in New York City and graduated from Brown University in 1990 with a degree in Biochemistry and from Johns Hopkins Medical School in 1997 with an MD/PhD. He then joined the Whitehead Institute in Cambridge, Massachusetts as a Whitehead Fellow, and in 2002 became a Member, at which time he was also appointed to the faculty of the Massachusetts Institute of Technology, where he is now a Professor of Biology. He is also an Investigator of the Howard Hughes Medical Institute and has appointments at the Broad Institute of MIT and Harvard and at the Koch Institute for Integrative Cancer Research at MIT. Sabatini has received several awards, including the 2009 Paul Marks Prize for Cancer Research, the 2012 Earl and Thressa Stadtman Scholar Award, and the 2014 National Academy of Sciences Award in Molecular Biology. He was elected to the National Academy of Sciences in 2016.
David received the 2020 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine, and most recently, the 2020 Sjöberg Prize.